WNT10B protein expression was more highly expressed in TNBC (80%) compared to other subtypes of breast cancer (10% in ER+/Her2+/PR+) and significantly predicted worse survival outcomes, tumor size, and grade, suggesting, for the first time, that WNT10B expression is clinically relevant in breast cancer. Here, ERBB2 is linked to breast carcinoma.